Keyphrases
Mammalian Target of Rapamycin (mTOR)
100%
Tumor Immunity
100%
Selective Inhibition
100%
Tumor Vessels
100%
Tumor Growth
40%
Tumor Cells
40%
Tumor Metastasis
40%
MTOR Inhibitor
40%
Tumor Vessel Normalization
40%
Tumor
20%
MTORC1 Signaling
20%
Cell-to-cell
20%
High Dose
20%
Endothelial Cells
20%
Granulocyte Colony-stimulating Factor (G-CSF)
20%
CD103+ Dendritic Cells
20%
Solid Tumors
20%
Endothelium
20%
Human Tumors
20%
Immune Cells
20%
Immune Function
20%
Tumor Endothelial Cells
20%
Cancer Therapeutics
20%
Oncology Patients
20%
Angiogenic Factors
20%
Immune Cell Trafficking
20%
Immune Therapy
20%
Gene Ablation
20%
Everolimus
20%
Inducible Genes
20%
Signaling Nodes
20%
Tissue Perfusion
20%
PI3K Signaling
20%
T Cell Depletion
20%
Tumor-immune System
20%
Cancer Metastasis
20%
Raptor
20%
Tumor-infiltrating Lymphocytes
20%
Tumor Blood Vessels
20%
Anti-tumor Immune
20%
Therapeutic Responsiveness
20%
Actionable Target
20%
RAD001
20%
Immunology and Microbiology
Immunocompetent Cell
100%
Tumor Cell
100%
Everolimus
100%
Dendritic Cell
50%
Low Drug Dose
50%
Drug Megadose
50%
Cell Migration
50%
Immunotherapy
50%
Granulocyte Macrophage Colony-Stimulating Factor
50%
Neutralization
50%
Immunity
50%
Angiogenic Factor
50%
Animal Experiment
50%
T Cell Depletion
50%
Tumor-Infiltrating Lymphocytes
50%
Tissue Perfusion
50%
Biochemistry, Genetics and Molecular Biology
Tumor Progression
100%
Immunocompetent Cell
100%
Immunity
100%
Drug Megadose
50%
Granulocyte Macrophage Colony-Stimulating Factor
50%
Low Drug Dose
50%
Dendritic Cell
50%
Cell Migration
50%
Tissue Perfusion
50%
Animal Experiment
50%
Tumor-Infiltrating Lymphocytes
50%
T Cell Depletion
50%
Medicine and Dentistry
Neoplasm
100%
Metastatic Carcinoma
50%
Immunocompetent Cell
33%
Tumor Cell
33%
Endothelial Cell
33%
Tumor Progression
33%
Everolimus
33%
Dendritic Cell
16%
Immunotherapy
16%
T Cell
16%
Drug Megadose
16%
Low Drug Dose
16%
Solid Malignant Neoplasm
16%
Oncology
16%
Vascular Tissue Neoplasm
16%
Cell Migration
16%
Immune Function
16%
Perfusion
16%
Tumor Infiltrating Lymphocyte
16%
Granulocyte Macrophage Colony Stimulating Factor
16%
Neutralization
16%
Angiogenic Factor
16%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Metastasis
33%
Tumor Growth
22%
Everolimus
22%
Solid Malignant Neoplasm
11%
Granulocyte Macrophage Colony Stimulating Factor
11%
Immunotherapy
11%
Vascular Tumor
11%
Angiogenic Factor
11%